A Phase 1 Study of Fianlimab (Anti-Lag-3) in Combination with Cemiplimab (Anti-Pd-1) in Patients with Advanced Ccrcc.
JOURNAL OF CLINICAL ONCOLOGY（2024）
关键词
283-424-3231-2482,261-492-199-2823-9473,298-145-222-184-4809-5347,613-615-646-2548-6275,261-492-3532-2370-5109,3926,2416,3926,2416,38092-26004
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要